SEARCH · PubMed Health

Results for “EXUDATES AND TRANSUDATES”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 289 records · Page 16Linked to original sources

PubMed1994

Pleural effusion: a clinical review.

Pleural effusion is a problem commonly encountered by chest physicians, accounting for approximately 4% of all attendances to the chest clinic. In spite of extensive investigations, a significant proportion (approximately 20%) of effusions defy a diagnostic label. This article discusses the role of established, and some of the newer, techniques which are now available for investigating pleural disease in a clinical setting. The initial approach towards a diagnosis usually begins by distinguishing between transudates and exudates, based on protein and lactate dehydrogenase (LDH) concentrations in fluid (usually in relation to their concentration in serum). The exact role of amylase and LDH (and their isoenzymes) may provide additional information towards a differential diagnosis of various exudative pleural effusions. With newer cytochemical staining techniques on pleural fluid, the diagnostic yield of malignant pleural effusions may be increased by up to 80%. Ultrasound (US) and computed tomographic (CT) scan of the chest have further enhanced the diagnostic yield of undiagnosed pleural effusions, especially in relation to the US or CT guided needle biopsy. The re-emergence of thoracoscopy as the latest diagnostic and therapeutic (e.g. pleurodesis) tool for undiagnosed or recurrent pleural effusions, may help in narrowing the diagnostic dilemma faced by clinicians.

Humans↗

PubMed1997

[Bronchoscopic assessment algorithms for the practical evaluation of the rheological properties of the tracheobronchial secretion and the classification of the degree of the disordered drainage function of the tracheobronchial tree (TBT) in chest and combined trauma with chest trauma as the leading injury].

Ventilation impairment, due to ineffective elimination of the mucous-hemorrhagic content from the tracheobronchial tree (TBT), obstructs the upper airways with the ensuing ventilation reduction giving rise to atelectases and progressive alveolar block. There is evidence of transudation and exudation into the pulmonary pathways and pleural cavity. A series of 276 patients presenting closed chest trauma are subjected to fibrobronchoscopy (FBS) and follow-up study. In 92 of them bronchoscopy is performed 2 to 15 times per patient, accordingly: in 75-twice, in 10-five times and in 15-twice. One-hundred twenty-nine of the total of 276 cases under study are on mechanical ventilation. In 56 instances FBS is carried out through a tracheostomy cannula, in 73-by intubation, in 18-through the mouth, and in two--through the nose. Based on the obtained results, algorithms for assessment of the rheological properties of tracheobronchial secretion and degree of impairment of TBT drainage function during emergency FBS in closed chest injuries are worked out, having an essential practical bearing on the diagnostic and therapeutic approach to closed thoracic trauma.

Algorithms↗

PubMedDate not supplied

Pleural fluid and serum soluble interleukin-2 receptors in pleural effusions.

Pleural fluid and serum soluble Interleukin-2 receptors (sIL-2R) were measured by an enzyme-immunoassay in 13 patients with tuberculous pleurisy, in 28 patients with carcinomatous pleurisy and in 17 transudates from patients with congestive heart failure. Significantly higher values of sIL-2R were observed in exudative than in transudative (mean +/- SEM = 713 +/- 111 U/ml) pleural fluid samples, the highest being found in tuberculous (3777 +/- 501 U/ml) and the intermediate in carcinomatous exudates (1981 +/- 160 U/ml) (p less than 0.0001; on way ANOVA). Serum sIL-2R were significantly higher in carcinomatous and transudative groups than in age- and sex- matched controls (p less than 0.002; one way ANOVA), while there was no significant difference between the tuberculous group and controls. The pleural/serum sIL-2R ratio was significantly higher in tuberculous (5.32 +/- 0.60), than in carcinomatous pleurisy (2.67 +/- 0.20) and higher still than in transudates (0.76 +/- 0.10) (p less than 0.001; one way ANOVA). In conclusion, the pleura/serum sIL-2R ratio may be a helpful parameter in differentiating tuberculous from carcinomatous pleurisy and an additional confirmatory one for distinguishing transudates from exudates.

Adult↗

PubMed2006

Diagnostic approach to pleural effusion in adults.

The first step in the evaluation of patients with pleural effusion is to determine whether the effusion is a transudate or an exudate. An exudative effusion is diagnosed if the patient meets Light's criteria. The serum to pleural fluid protein or albumin gradients may help better categorize the occasional transudate misidentified as an exudate by these criteria. If the patient has a transudative effusion, therapy should be directed toward the underlying heart failure or cirrhosis. If the patient has an exudative effusion, attempts should be made to define the etiology. Pneumonia, cancer, tuberculosis, and pulmonary embolism account for most exudative effusions. Many pleural fluid tests are useful in the differential diagnosis of exudative effusions. Other tests helpful for diagnosis include helical computed tomography and thoracoscopy.

Adult↗

PubMedDate not supplied